Evidence map›Paper›PMID 30405111›Full record

ArticleEmerging microbes & infections2018

Immunogenicity and protective efficacy against Treponema pallidum in New Zealand rabbits immunized with plasmid DNA encoding flagellin.

Kang Zheng, Man Xu, Yongjian Xiao, Haodang Luo, Yafeng Xie, Jian Yu, Manyi Tan, Yumeng Li, Feijun Zhao, Tiebing Zeng and 1 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Emerging microbes & infections, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Emerging microbes & infections · 2024
    Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Immunization with Tp0954, an adhesin ofFrontiers in immunology · 2023
    Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Frontiers in immunology · 2020
    Article
  20. Characterization ofFrontiers in immunology · 2020
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Kang ZhengInstitute of Pathogenic Biology, Medical College, University of South China, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, Hengyang, 421001, China.
Man XuInstitute of Pathogenic Biology, Medical College, University of South China, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, Hengyang, 421001, China.
Yongjian XiaoClinical Laboratory, The Second Affiliated Hospital of University of South China, Hengyang, 421001, China.
Haodang LuoInstitute of Pathogenic Biology, Medical College, University of South China, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, Hengyang, 421001, China.
Yafeng XieClinical Laboratory, The Second Affiliated Hospital of University of South China, Hengyang, 421001, China.
Jian YuInstitute of Pathogenic Biology, Medical College, University of South China, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, Hengyang, 421001, China.
Manyi TanInstitute of Pathogenic Biology, Medical College, University of South China, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, Hengyang, 421001, China.
Yumeng LiInstitute of Pathogenic Biology, Medical College, University of South China, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, Hengyang, 421001, China.
Feijun ZhaoInstitute of Pathogenic Biology, Medical College, University of South China, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, Hengyang, 421001, China.
Tiebing ZengInstitute of Pathogenic Biology, Medical College, University of South China, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, Hengyang, 421001, China.
Yimou WuInstitute of Pathogenic Biology, Medical College, University of South China, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, Hengyang, 421001, China. yimouwu@sina.com.
University of South China · CN

Funding

National Natural Science Foundation of China (National Science Foundation of China) 81471576, 81702046, 81701577, and 81373230
6 · The paper itself

Abstract

Plasmid DNA encoding flagellin FlaB3 was used as a vaccination candidate for the evaluation of immunogenicity and protection against Treponema pallidum subsp. pallidum dissemination. First, intramuscular injection of the flagellin encoded by the plasmid DNA into New Zealand rabbits elicited both humoral and cellular immune responses. Total IgG production increased in response to flagellin. In addition, serum IFN-γ secretion and CD8+ cells were substantially greater in the rabbits immunized with the plasmid encoding flagellin FlaB3 than those in the rabbits immunized with recombinant flagellin. The flagellin encoded by the plasmid DNA induced significant upregulation of serum IL-6 and IL-8 compared to that of the control rabbits. Subsequently, intradermal challenge of the vaccinated New Zealand rabbits with 1 × 10

Indexed as

Immunogenicity, VaccineAdjuvants, ImmunologicAnimalsBacterial LoadBacterial VaccinesCD8-Positive T-LymphocytesCytokinesFlagellinHeLa CellsHumansImmunity, CellularImmunity, HumoralImmunoglobulin GInjections, IntramuscularInterferon-gammaPlasmidsAdjuvants, ImmunologicBacterial VaccinesCytokinesFlagellinImmunoglobulin GInterferon-gammaVaccines, DNA

Identifiers

PMID30405111
PMCPMC6220273
OpenAlexW2900063344

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.